The role of MRI and MRSI in diagnosis, treatment selection, and post-treatment follow-up for prostate cancer

Michael Fuchsjäger, Oguz Akin, Amita Shukla-Dave, Darko Pucar, Hedvig Hricak

Research output: Contribution to journalReview article

24 Scopus citations


Magnetic resonance imaging (MRI) is increasingly being recognized as a valuable tool for the assessment of prostate cancer. In recent years, MRI technology has matured, image acquisition and interpretation have improved, and a multitude of clinical studies have demonstrated the potential of MRI techniques for contributing to prostate cancer care. This review will provide a brief overview of MRI techniques relevant to prostate cancer, including MR spectroscopic imaging, and discuss the ways that they can aid in diagnosis, treatment selection, and post-treatment follow-up.

Original languageEnglish (US)
Pages (from-to)193-202
Number of pages10
JournalClinical Advances in Hematology and Oncology
Issue number3
StatePublished - Jun 9 2009



  • Dynamic contrast-enhanced magnetic resonance imaging
  • Magnetic resonance imaging
  • Prostate cancer
  • Spectroscopic imaging

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this